Bumper Offer - Urjas oil Just @ Rs. 1
Dapanorm M Tablet is an allopathic medicine The correct dosage of Dapanorm M Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Dapanorm M Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Dapanorm M Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Dapanorm M Tablet safe for pregnant women?
Dapanorm M Tablet can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Dapanorm M Tablet safe during breastfeeding?
There is no research available on the side effects of Dapanorm M Tablet in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Dapanorm M Tablet on the Kidneys?
Dapanorm M Tablet may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Dapanorm M Tablet on the Liver?
There may be an adverse effect on the liver after taking Dapanorm M Tablet. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Dapanorm M Tablet on the Heart?
Information about safety of Dapanorm M Tablet for heart is not available since scientific research on this is yet to be done.
Dapanorm M Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Dapanorm M Tablet unless your doctor advises you to do so -
Is this Dapanorm M Tablet habit forming or addictive?
No, you will not get addicted to Dapanorm M Tablet .
Interaction between Food and Dapanorm M Tablet
Due to the absence of research, it is difficult to say how Dapanorm M Tablet and food will interact.
Interaction between Alcohol and Dapanorm M Tablet
Consuming Dapanorm M Tablet with alcohol can have many serious effects on your body.
Yes, Dapanorm M Tablet commonly cause stomach upset like diarrhea, abdominal pain, nausea, and vomiting. To avoid these side effects you should take Dapanorm M Tablet with your meal and increase the dose gradually.
Yes, you can take Dapanorm M Tablet with gliclazide, no harmful interactions have been reported between them. However, it is not necessary that no interaction can happen between these two. But before taking such kind of combination you must consult your doctor.
Yes, Dapanorm M Tablet is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
The long-term use can lead to the deficiency of Vitamin B12, which can further lead to megaloblastic anemia. Furthermore, Long-term Metformin use can also lead to kidney and liver problems.
No, you should not take alcohol with Dapanorm M Tablet, because it can cause serious side effects which includes hypoglycemia (low blood sugar). The risk of hypoglycemia is higher when you're drinking and taking Dapanorm M Tablet than if you're just taking Dapanorm M Tablet. Some of the signs of hypoglycemia include dizziness, confusion, and drowsiness.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278
